Cancer Diagnostics Market Size & Share, by Product (Platform Based and Instruments); Application (Breast Cancer, Melanoma, Colorectal Cancer, Lung Cancer); End User (Hospitals, Cancer Research Institute) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 2550
  • Published Date: Oct 15, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Cancer Diagnostics Market size was over USD 107.24 billion in 2023 and is anticipated to cross USD 234.41 billion by 2036, witnessing more than 6.2% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of cancer diagnostics is estimated at USD 112.56 billion.

This can be attributed to the rising incidence of cancer among people and inadequate medical infrastructure of middle and low income countries. According to World Health Organization, cancer is the second leading cause of death globally with 70% of the total deaths occurring in low and middle income countries.


Get more information on this report: Request Free Sample PDF

Cancer Diagnostics Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Incidence Rates of Cancer and Sedentary Lifestyle

Rising sedentary lifestyles of people living in the developing and developed countries has led to an increase in the number of head, lung and neck cancer cases as a result of improper posture. Additionally, the surge in consumption of tobacco & alcohol is estimated to result in a higher number of cancer cases. Further, the increasing awareness about diagnostics among the masses is predicted to be the main growth driver for the market. Some developing countries following traditional cancer treatment are now looking to adopt modern cancer diagnostic methods for earlier detection. Owing to these factors market is expected to grow during the forecast period.

  • Growing Geriatric Population

Increasing life expectancies in different countries across the world has led to significant growth in the older population. Countries such as Japan and China contain a larger number of elderly populations as a result of improved healthcare, political, economic and social conditions. Consequently, complexity of diagnosis has also increased along with the demand for cancer diagnostics. Owing to these factors, market is expected to grow during the forecast period.

  • Need for Evidence Based Approach towards Cancer Diagnosis

There is substantial evidence available through randomized controlled trials concluding that the adoption of cancer diagnostics could significantly reduce the mortality rate caused by cancer. Additionally, people are becoming more inclined towards evidence based treatments with higher accuracy so that the entire process is swifter and has minimum side effects. On the back of these factors, cancer diagnostics market is anticipated to grow over the next few years.

  • Increasing Research and Development Activities

Extensive research and development activities being carried out by the government organizations and research universities are estimated to open up more opportunities for the sector along with increase the market growth over the forecast period.

  • Technological Advancements

Technological advancements in the fields that lead to the development of highly advanced medical products, equipment and treatments such as endoscopy, biomarkers, biopsy and imaging are predicted to drive the market growth in future.

Challenges

  • Radiation risks from imaging tests

The radiations emitted from various imaging tests could increase the risk of developing a cancer later in the life of the person. This is estimated to negatively affect the market growth over the forecast period. However, newer diagnostic methods are being developed that are better and are anticipated to make this risk negligible.

  • Lack of skilled professionals

Cancer diagnostics require technically skilled professionals. As there is already a dearth of healthcare professionals across the world, it is predicted to hamper the market growth in the forecast period.

 

Cancer Diagnostics Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

6.2%

Base Year Market Size (2023)

USD 107.24 billion

Forecast Year Market Size (2036)

USD 234.41 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
 

 

Get more information on this report: Request Free Sample PDF

Cancer Diagnostics Segmentation

The market is segmented by product into platform based products and instruments, out of which, the instrument segment is anticipated to grow at the highest rate in the cancer diagnostics market on account of rising cancer cases, growing geriatric population, technological advancements and increasing sedentary lifestyle. 

Our in-depth analysis of the global market includes the following segments:

           By Product

  • Platform Based
  • Instruments

             By Application

  • Breast Cancer
  • Melanoma
  • Colorectal cancer
  • Lung cancer
  • Others

By End User

  • Hospitals
  • Cancer research institutes
  • Others
 

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Cancer Diagnostics Industry - Regional Synopsis

On the basis of regional analysis, the cancer diagnostics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America industry is poised to hold largest revenue share by 2036, backed by increasing geriatric population, rising research and development initiatives by the government, increasing cancer cases among the population and need for evidence based treatment for cancer. On the other hand, the market in Asia Pacific is anticipated to grow at the highest CAGR over the forecast period on the back of improving health infrastructure, rising cancer cases and increasing geriatric population in the region.

Get more information on this report: Request Free Sample PDF

Companies Dominating the Cancer Diagnostics Landscape

    • Siemens Healthcare Gmbh
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • GE Healthcare
    • Abbott
    • Becton, Dickinson & Company
    • Illumina Inc.
    • Hologic Inc.
    • F.Hoffman-La Roche
    • Qiagen NV
    • Phillips Healthcare
    • CR Bard Inc.
    • Agilent Technologies Inc.
    • Thermo Fisher Scientific Inc.
    • Biocartis SA
    • Biocare Medical LLC
    • Cancer Genetics Inc.
    • Myriad Genetics

In the News

  • April 20, 2020: Researchers from University of Adelaide and Institute for Glycomics announced that they have engineered a protein called SubB2M that binds to the sugar molecules present in cancer cells and detects its presence in cancer patients. 

Author Credits:  Radhika Pawar


  • Report ID: 2550
  • Published Date: Oct 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of cancer diagnostics is estimated at USD 112.56 billion.

Cancer Diagnostics Market size was over USD 107.24 billion in 2023 and is anticipated to cross USD 234.41 billion by 2036, witnessing more than 6.2% CAGR during the forecast period i.e., between 2024-2036.

North America industry is poised to hold largest revenue share by 2036, backed by increasing geriatric population, rising research and development initiatives by the government, increasing cancer cases among the population and need for evidence based treatment for cancer.

The major players in the market are Siemens Healthcare Gmbh, GE Healthcare, Abbott, Becton, Dickinson & Company, Illumina Inc., Hologic Inc., F.Hoffman-La Roche, Qiagen NV, Phillips Healthcare, CR Bard Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., Biocartis SA, Biocare Medical LLC, Cancer Genetics Inc., Myriad Genetics, and others.
Cancer Diagnostics Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample